Erratum to Glycated albumin as a useful clinical biomarker for glycemic variability in type 1 diabetes assessed by continuous glucose monitoring (Diabetol Int, (2013), 4, (156-159), 10.1007/s13340-013-0108-0);Glycated albumin as a useful clinical biomarker for glycemic variability in type 1 diabetes assessed by continuous glucose monitoring

Diabetology International

Volumn 4, Issue 3, 2013, Pages 156-159

  Tsutsumi, Chiharu ^a   Imagawa, Akihisa ^a,b   Onishi, Mineki ^a   Sano, Hiroyuki ^a   Nakagawa, Seiko ^a   Murase Mishiba, Yuko ^a   Terasaki, Jungo ^a   Hanafusa, Toshiaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CGM; Glycated albumin; HbA1c; Type 1 diabetes

Indexed keywords

GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; DISEASE DURATION; DISEASE MARKER; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCEMIC INDEX; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL;

EID: 84884871002     PISSN: 21901678     EISSN: 21901686     Source Type: Journal    
DOI: 10.1007/s13340-013-0142-y     Document Type: Erratum

References (14)

1. Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes therapy and carotid intima-media thickness in Type 1 diabetes mellitus. N Engl J Med. 2003;348: 2294-303.
2. Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes JW. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA. 1979;76: 4258-61.
3. Day JF, Ingebretsen CG, Ingebretsen WR, Baynes JW, Thorpe SR. Nonenzymatic glycosylation of serum protein and hemoglobin: response to changes in blood glucose levels in diabetic rats. Diabetes. 1980;29: 524-7.
4. Matsumoto H, Murase-Mishiba Y, Yamamoto N, Sugitatsu-Nakatsukasa S, Shibasaki S, Sano H, Terasaki J, Imagawa A, Hanafusa T. Glycated albumin to glycated hemoglobin ratio is a sensitive indicator of blood glucose variability in patients with fulminant type 1 diabetes. Intern Med. 2012;51(11): 1315-21.
5. Yoshiuchi K, Matsuhisa M, Katakami N, Nakatani Y, Sakamoto K, Matsuoka T, Umayahara Y, Kosugi K, Kaneto H, Yamasaki Y, Hori M. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J. 2008;55: 503-7.
6. Koga M, Murai J, Saito H, Aoki K, Kanehara H, Bando Y, Morita S, Kasayma S. Glycated albumin levels are higher relative to HbA1c levels in people with autoimmune acute-onset type 1 diabetes mellitus than in people with type 2 diabetes mellitus at the time of diagnosis. Diabetes Res Clin Pract. 2011;94: e12-4.
7. Wójcicki JM. "J"-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res. 1995;27: 41-2.
8. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke W. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care. 1998;21: 1870-5.
9. Schlichtkrull J, Munck O, Jersild M. The M-valve, an index of blood-sugar control in diabetics. Acta Med Scand. 1965;177: 95-102.
10. Molnar GD, Taylor WF, Ho MM. Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability. Diabetologia. 1972;8: 342-8.
11. Czerwoniuk D, Fendler W, Walenciak L, Mlynarski W. GlyCulator: a glycemic variability calculation tool for continuous glucose monitoring data. J Diabetes Sci Technol. 2011;5: 447-51.
12. Rodbard D. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther. 2009;11(Suppl 1): S55-67.
13. Rodbard D. The challenges of measuring glycemic variability. J Diabetes Sci Technol. 2012;6(3): 712-5.
14. Ogawa A, Hayashi A, Kishihara E, Yoshino S, Takeuchi A, Shichiri M. New indices for predicting glycaemic variability. PLoS ONE. 2012;7: e46517.